CVE-2016-6657

Description

An open redirect vulnerability has been detected with some Pivotal Cloud Foundry Elastic Runtime components. Users of affected versions should apply the following mitigation: Upgrade PCF Elastic Runtime 1.8.x versions to 1.8.12 or later. Upgrade PCF Ops Manager 1.7.x versions to 1.7.18 or later and 1.8.x versions to 1.8.10 or later.

Category

7.4
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.19%
Vendor Advisory pivotal.io
Affected: n/a PCF Elastic Runtime 1.8.x versions prior to 1.8.12 and PCF Ops Manager 1.7.x versions prior to 1.7.18 and 1.8.x versions prior to 1.8.10
Published at:
Updated at:

References

Link Tags
https://pivotal.io/security/cve-2016-6657 mitigation vendor advisory
http://www.securityfocus.com/bid/94126 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2016-6657?
CVE-2016-6657 has been scored as a high severity vulnerability.
How to fix CVE-2016-6657?
To fix CVE-2016-6657, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-6657 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2016-6657 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2016-6657?
CVE-2016-6657 affects n/a PCF Elastic Runtime 1.8.x versions prior to 1.8.12 and PCF Ops Manager 1.7.x versions prior to 1.7.18 and 1.8.x versions prior to 1.8.10.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.